COSCO SHIPPING Terminals Release Q1 Results
Facing the outbreak of COVID-19, terminals under COSCO SHIPPING Ports (CSP) published their hard-won business results for the first quarter of 2020.
2026-08-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
Three Major Indian Chemical Investments Target China's PC Exports
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
South Korea Initiates Anti-Dumping Probe on Chinese PVC Suspension Resin, Involving Tianjin Bohua and Wanhua Chemical
-
China Keeps Registering Pesticides
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
INEOS Warns Chinese Chemical “Dumping” Is Hitting Europe’s Industry
-
Covestro Builds New 660,000-ton MDI Plant in China: Global Supply Gap Meets Chinese Overcapacity Head-On
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
EU Finalizes Anti-Dumping Duties on BDO from China, with Rates up to 113.7%
Recommend Reading
-
India’s Pharma Cost Problem Gets Worse
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
After Two Rounds of Price Cuts, the Coke Market Stabilizes in China
-
The FDA Officially Blesses AI for Liver Drug Development
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI